Call for proposals - Laboratories


Call for proposals - Laboratories

The Fondation Pour l’Audition (FPA) offers two call for proposals:
- One to support French research laboratories in the field of hearing sciences, including basic, applied, clinical, sociological and epidemiological research.
- One to support translational research.

Call for research proposal laboratoriesThe aim is to support new approaches, to promote multidisciplinary research and, more broadly, to implement innovations and outcomes in order to improve hearing health in the short or long term.

Deadline for application: CLOSED


Applications must comply with FPA’s mission to improve hearing health and promote translational research in the following fields:


  • Auditory pathways and networks
  • Drug delivery,
  • Gene cell and pharmacological therapies,
  • Pathophysiology of hearing disorders and tinnitus.


  • Cohorts
  • Epidemiological studies
  • Development of new audiological diagnostic and screening tests and assessment tools
  • Psychoacoustics and psychophysics


  • Rehabilitation
  • Patient management
  • Treatment


  • Public health implication of hearing loss: psychological, physical and/or social aspects of hearing loss.


The overall budget of the 2020 call for proposals is set to 900,000 euros. Each project will be funded up to 100,000 euros per year for up to 3 years. The funding is provided annually; continuation of support for an additional two years is based on a report to be evaluated by the Scientific Committee.


FPA grants are awarded to French teams in academic or clinical public research institutions. International collaborations are encouraged. The principal investigator and co-investigators must hold a faculty appointment (position equivalent to assistant professor or higher) in order to be eligible for a grant from FPA.
Laboratories are ineligible for funding if they hold an active FPA award. Projects involving a member of the FPA Scientific Committee or Board of Directors and his/her laboratory are not eligible for an FPA research grant. Research teams joining the Institut de l’Audition in Paris and teams participating to the CeRCA network are also ineligible for funding.


The call is organized in five stages:

  1. Submission of a pre-proposal reviewed by the Scientific Committee.
  2. Submission of a full proposal for selected pre-proposals.
  3. Full proposal review by international reviewers.
  4. Selection of full proposals by the Scientific Committee.
  5. Approval of the Board of Directors.


To apply to the call for proposals, download the relevant form below. No other form will be accepted. Read and follow the instructions carefully provided in the policies and guidelines of the call for proposals.


Your contact
Tél : +33 1 55 78 20 10


Translational Research Initiative for Hearing Grant

Go to the dedicated page !

The Translational Research Initiative for Hearing (TRIH) Grant helps move research closer to patients. The grant is international. We fund applied research projects at research institutes and small to medium enterprises (SMEs) across the world. This year, Fondation Pour l’Audition and Action on Hearing Loss are partnering to co-fund the TRIH grant.

The TRIH Grant supports:

  • research with strong commercial potential, likely to attract follow-on funding at the conclusion of the grant.
  • studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.

The TRIH Grant does not support basic research into the causes and underpinning biology of hearing loss and tinnitus or the development of devices or software.

2020 TRIH Grant

  • Duration: up to three years
  • Eligibility: applicants may be from any country and may be from academic institutions and small/medium enterprises (SMEs)
  • Value: Up to £100,000 per year

Application procedure

First, an expression of interest must be submitted. This gives us enough information about the proposed project to understand how well it aligns with the requirements and eligibility of the TRIH scheme.

Applicants whose proposals meet the criteria of the scheme are then invited to submit a full application.


This year, the scope of the Translational Research Initiative for Hearing call includes : Small molecule, gene or cell-based approaches for the treatment of hearing loss or tinnitus.

Applications can include:

  • studies which will enable lead optimisation and/or candidate selection
  • pharmacokinetics/Pharmacodynamics (PKPD) studies
  • safety/toxicology studies
  • drug repositioning/repurposing (applications must contain preliminary data supporting the proposed approach)
  • validation of therapeutic targets for the treatment of hearing loss or tinnitus (applications must contain preliminary data supporting the proposed approach)
  • studies to strengthen confidence that a target or therapeutic approach will be applicable to human hearing loss or tinnitus
  • identification/validation of methods or outcomes that could be used for one or more of the following*:
  • patient selection/stratification for clinical trials
  • robust measurement of treatment responses in clinical trials.

*Please note that these studies must support the development of a specific therapeutic. General research into outcome measures not aligned to a specific therapeutic should be submitted to other grant schemes of FondationPour l'Audition (call for laboratories) and Action on Hearing Loss (i.e Discovery Research Grant Scheme).

Areas in which applications will NOT be accepted:

  • basic research into the causes and underpinning biology of hearing loss and tinnitus
  • the development of devices or software
  • the optimisation of current clinical protocols
  • health service studies.

How to apply

Go to

For more